0.9460EUR-1.87%Mkt Cap: 66.01M EURP/E: —Last update: 2026-06-01
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cance…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap66.01M EUR
Enterprise Value—
Revenue (TTM)1.17M EUR
Gross Profit978.00K EUR
Net Income (TTM)-1.56M EUR
Revenue/Share0.0230 EUR
Last Price0.9460 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0010557264
Valuation
P/E (Trailing)—
P/E (Forward)-6.89
PEG—
EV/EBITDA—
EV/Revenue—
P/S57.29
P/B-2.35
EPS (TTM)-0.03
EPS (Forward)-0.14
52W Range
0.93002% of range1.730
52W High1.730 EUR
52W Low0.9300 EUR
Profitability
Gross Margin83.30%
Oper. Margin510.93%
EBITDA Margin87.99%
Profit Margin-132.62%
ROE9.05%
ROA-6.35%
Growth
Revenue Growth28.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.29M EUR
CapEx (TTM)282.00K EUR
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-1.10
Current Ratio—
Quick Ratio—
Book Value/Sh-0.4110 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)4.485 EUR
Target Range4.485 EUR – 4.485 EUR
# Analysts1
Ownership
Shares Out.69.78M
Float21.02M
Insiders29.22%
Institutions0.00%
Technical
SMA 501.098 (-13.8%)
SMA 2001.235 (-23.4%)
Beta1.18
S&P 52W Chg27.94%
Avg Vol (30d)301.50K
Avg Vol (10d)294.74K
Technical Indicators
RSI (14)39.2
MACD-0.0409
MACD Signal-0.0480
MACD Hist.+0.0071
BB Upper1.022 EUR
BB Middle0.9738 EUR
BB Lower0.9258 EUR
BB Width9.87%
ATR (14)0.0424 EUR
Vol Ratio (20d)0.65x